Onderzoeker
Jacques De Grève
- Trefwoorden:Geneeskunde
- Disciplines:Kankertherapie, Kankerbiologie, Kankerpreventie
Affiliaties
- Medische genetica (Departement)
Lid
Vanaf1 mei 2019 → Heden - Laboratorium Moleculaire Oncologie (Onderzoeksgroep)
Lid
Vanaf1 jan 2010 → Heden - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf27 mei 2019 → 30 sep 2019 - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf1 jan 2014 → 30 sep 2022 - Medische Oncologie (Departement)
Lid
Vanaf1 jul 2012 → 30 apr 2019 - Medische Oncologie (Departement)
Lid
Vanaf1 jun 2010 → 31 dec 2011 - Inwendige Geneeskundige Specialiteiten (Departement)
Lid
Vanaf25 apr 2005 → 31 dec 2013 - Medische Beeldvorming en Fysische Wetenschappen (Departement)
Lid
Vanaf1 jan 1999 → 24 apr 2005
Projecten
1 - 6 of 6
- Interdiscliplinair Netwerk in Fundamenteel en Medisch Onderzoek op Long- en PancreaskankerVanaf1 jul 2021 → HedenFinanciering: BOF - projecten
- SRP-Groeifinanciering: Molecular Portrait of Pancreatic Tumours: Veni, vidi, viciVanaf1 mrt 2019 → HedenFinanciering: Univ. - Projectmatig onderzoek
- Interdisciplinair Netwerk voor Fundamenteel en Medische Onderzoek naar LongkankerVanaf1 jul 2016 → 30 jun 2021Financiering: Univ. - Projectmatig onderzoek
- Innovatie door Combinatie: Identificatie van een nieuwe combinatietherapie voor verbeterde behandeling van EGFRVanaf1 jan 2016 → 31 dec 2019Financiering: FWO mandaten
- BruBreast: Ontwikkeling van diagnostische en therapeutische instrumenten voor het optimale beheer van de individuele kankerpatiënt.Vanaf1 jun 2008 → 31 mei 2011Financiering: Brussels Hoofdstedelijk Gewest
- Kritische mutaties en signalen in borstkankercellen en hun stromale omgeving.Vanaf1 jan 2008 → 31 dec 2009Financiering: FWO Onderzoeksproject
Publicaties
1 - 10 van 141
- Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia(2023)
Auteurs: Robert J Kreitman, Philippe Moreau, Farhad Ravandi, Martin Hutchings, Anas Gazzah, Anne-Sophie Michallet, Zev A Wainberg, Alexander Stein, Sascha Dietrich, Maja J A de Jonge, et al.
Pagina's: 996-1006 - Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells(2023)
Auteurs: Mathias Elsocht, Philippe Giron, Jacques De Greve, Steven Ballet
- PRECISION(2022)
Auteurs: J Thouvenin, C Van Marcke, Lore Decoster, Gordana Raicevic, Kevin Punie, M. Vandenbulcke, R A Salgado, Els Van Valckenborgh, B Maes, Sofie Joris, et al.
- The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer(2022)
Auteurs: Carolien Eggermont, Philippe Giron, Amir Noeparast, Hugo Vandenplas, Pedro Aza-Blanc, Gustavo J Gutierrez, Jacques De Greve
- Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer(2022)
Auteurs: Sofie Joris, Christel Fontaine, Lore Decoster, Jacques Vanderauwera, Kris Thielemans, Wim Waelput, Jacques De Greve
Pagina's: 1433-1437 - Choroidal and Choriocapillaris Morphology in Pan-FGFR Inhibitor-Associated Retinopathy: A Case Report(2022)
Auteurs: Giuseppe Fasolino, Pieter Nelis, Marcel Ten Tusscher, Laura Moschetta, Jacques De Greve, Pierre Lefesvre
Pagina's: 1-7 - Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR)(2022)
Auteurs: Patrick Y Wen, Alexander Stein, Martin J van den Bent, Jacques De Greve, Antje Wick, Filip Y F L de Vos, Nikolas von Bubnoff, Myra E van Linde, Albert Lai, Gerald W Prager, et al.
Pagina's: 53-64 - Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth(2021)
Auteurs: Eva Reijmen, Sven de Mey, Helena Van Damme, Kirsten De Ridder, Thierry Gevaert, Emmy De Blay, Luc Bouwens, C. Collen, Lore Decoster, Marijke De Couck, et al.
- Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication(2021)
Auteurs: D Miles, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, M. Campone, I Bondarenko, Z Nowecki, H Errihani, S Paluch-Shimon, et al.
Pagina's: 1245-1255 - Fractionated Radiation Severely Reduces the Number of CD8+ T Cells and Mature Antigen Presenting Cells Within Lung Tumors(2021)
Auteurs: Eva Reijmen, Sven de Mey, Wout de Mey, Thierry Gevaert, Kirsten De Ridder, Hanne Locy, Sandrina Martens, Emmy De Blay, Luc Bouwens, P Debie, et al.
Pagina's: 272-283
Gelinkte datasets
1 - 6 van 6
- Additional file 6: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)
- Additional file 1: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)
- Additional file 4: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)
- Additional file 11: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)
- Additional file 3: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)
- Additional file 9: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)